Market Forecast By Prescription Type (Prescription Drugs, Over-the-Counter Drugs), By Drug Type (Branded Drugs, Generic Drugs, Branded Generic Drugs), By Drug Class (Small Molecules, Biologics, Biosimilars), By Indication (Cardiovascular Diseases, Immunology, Respiratory Diseases, Neurological Diseases, Infectious Diseases, Skin Diseases), By Mode of Administration (Topical, Oral, Injectable, Intra-nasal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And Competitive Landscape
| Product Code: ETC8978408 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights
Below mentioned are the evaluation of year-wise growth rate along with key drivers:
| Year | Est. Annual Growth (%) | Growth Drivers |
| 2021 | 5.8 | High demand for prescription drugs and healthcare initiatives by government |
| 2022 | 6 | Development of retail pharmacies and high risks of chronic diseases. |
| 2023 | 6.2 | Production of biologics and biosimilars, major improvement in healthcare infrastructure. |
| 2024 | 6.5 | High risks of lifestyle diseases, higher sales of over-the-counter drugs, and expansion of private healthcare facilities. |
| 2025 | 6.8 | New technologies in drug delivery and collaborations with global pharmaceutical companies. |
The Romania Pharmaceutical Market report thoroughly covers the market by prescription type, drug type, drug class, indication, mode of administration, and distribution channel. It provides an unbiased and detailed analysis of ongoing market trends, opportunities, challenges, and market drivers, helping stakeholders align their strategies with current and future market dynamics.
| Report Name | Romania Pharmaceutical Market |
| Forecast period | 2026-2032 |
| CAGR | 7.5% |
| Growing Sector | Healthcare & Pharmaceuticals |
Romania Pharmaceutical Market is poised for major growth due to several factors such as the high risk of chronic diseases, improved awareness about healthcare, and the development of healthcare infrastructure. The increasing number of collaborations between local and international pharmaceutical companies improves the drug portfolio available in Romania. The market also holds major growth potential due to high demand for both prescription and over-the-counter medications. Romania Pharmaceutical Market Growth is also supported by government programs that are focused on making medicines more affordable, the increased use of generic drugs and biosimilars, and the expansion of both retail and hospital pharmacies.
Below mentioned are some prominent drivers and their impact on the Romania Pharmaceutical Market dynamics:
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising Chronic Diseases | Prescription Drugs, OTC Drugs | Increased risks of cardiovascular, diabetes, and respiratory diseases has increased demand for pharmaceutical products. |
| Government Healthcare Programs | All Segments | Programs such as the Romanian National Health Insurance System and subsidies for essential medicines improve accessibility. |
| Expanding Retail & Hospital Pharmacies | All Segments | Expansion of retail and hospital pharmacies increases availability of drug in both urban and rural regions. |
| Rising Awareness & Health Literacy | All Segments | Increased health literacy creates higher demand for prescription and over-the-counter drugs. |
| International Collaborations | Branded Drugs, Biologics | Collaboration with global pharma companies to introduce new drugs and improve the quality of available medications. |
Romania Pharmaceutical Market is anticipated to grow at a CAGR of 7.5% from 2026 to 2032. This growth is due to several growth drivers which include the increasing risk of chronic diseases, healthcare programs by government, improvements in infrastructure, and collaborations with international pharmaceutical companies. The market is also majorly supported by high use of generic drugs and biosimilars which offers cost-effective alternatives in place of branded medicines. Increasing awareness and knowledge about health and rising spending in healthcare also likely to contribute to the market's growth potential.
Below mentioned are some major restraints and their influence on the Romania Pharmaceutical Market dynamics:
| Restraints | Primary Segment Affected | What This Means (Evidence) |
| High Cost of Branded Drugs | Branded Drugs | High prices of branded drugs reduce the sales, particularly in the low-income segments. |
| Regulatory Compliance | All Segments | Complex regulatory needs and lengthy drug approval processes may delay the introduction of new products. |
| Limited Local Manufacturing | Branded and Biologics | Over-dependence on imported drugs raises their prices and reduce challenges in the supply chain. |
| Economic Constraints | All Segments | Economic limitations lead to less spending on healthcare by certain population segments. |
| Counterfeit Drugs | OTC and Generic Drugs | The risks of counterfeit and fraud medicines reduce consumer’s trust in available pharmaceutical products. |
Romania Pharmaceutical Market faces many challenges such as high prices of branded drugs, regulatory difficulties, limited capabilities of local manufacturing, and fluctuations in the economy. Over-dependence on imported medicines affects the stability of pricing and availability. Counterfeit and frauds drugs and limited production capacity and trust add further strain in the market. The slow development of new therapies and limited knowledge about healthcare in rural areas may restrict demand in the market. Inefficiencies in logistics and distribution challenges also reduce the timely delivery of essential medicines.
Key trends shaping the Romania Pharmaceutical Market include:
Romania Pharmaceutical Industry presents many investment opportunities, including:
Below is the list of prominent companies leading in the Romania Pharmaceutical Market:
| Company Name | Sanofi S.A. |
|---|---|
| Headquarters | Paris, France |
| Established | 1973 |
| Website | Click Here |
Sanofi is a global pharmaceutical leader operating in Romania, offering a wide range of branded and generic drugs across various therapeutic areas, including cardiovascular and immunology.
| Company Name | Novartis AG |
|---|---|
| Headquarters | Basel, Switzerland |
| Established | 1996 |
| Website | Click Here |
Novartis provides innovative medicines and biosimilars in Romania, particularly for oncology, respiratory, and neurological treatments.
| Company Name | GlaxoSmithKline (GSK) |
|---|---|
| Headquarters | Brentford, United Kingdom |
| Established | 2000 |
| Website | Click Here |
GSK offers vaccines, prescription drugs, and OTC medicines in Romania, focusing on respiratory diseases, infections, and skin disorders.
| Company Name | Cipla Ltd. |
|---|---|
| Headquarters | Mumbai, India |
| Established | 1935 |
| Website | Click Here |
Cipla specializes in generic medicines, offering affordable options for cardiovascular, respiratory, and chronic disease management in Romania.
| Company Name | Medica Pharma |
|---|---|
| Headquarters | Bucharest, Romania |
| Established | 1994 |
| Website | - |
Medica Pharma is a leading Romanian pharmaceutical manufacturer offering a wide range of branded and generic drugs, focusing on domestic and regional markets.
According to Lakshita, Senior Research Analyst, 6Wresearch, they have implemented many important policies to strengthen the pharmaceutical sector of Romania. The National Health Insurance Scheme (NHI) plays an important role in improving access to healthcare for all citizens and making essential medicines more affordable. The Medicines Regulatory Authority (ANMDM) ensures the safety and efficacy of drugs by making their approval efficient. To further improve the domestic production, the government also offers tax incentives and subsidies to local pharmaceutical manufacturers which encourage growth in this sector. Public-private partnerships are actively promoted to create new innovation and facilitate modern medical technologies are also supporting the advancement of Romania Pharmaceutical Industry.
Romania Pharmaceutical Market is expected to continue its growth trajectory in the upcoming years as it is driven by the increasing risks of chronic diseases, government healthcare programs, and the development of healthcare infrastructure. The increasing usage of generic drugs, biologics, and biosimilars will likely continue to change market’s demand. The rise of digital pharmacies and telehealth services will improve quality of medications across Romania which positions it as a important pharmaceutical hub in the region. The increasing use of generic drugs and biosimilars, along with collaborations with international pharmaceutical companies will likely to boost the market demand.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Lakshita, Senior Research Analyst, 6Wresearch, Prescription Drugs dominate the Romania market due to increasing risk of chronic and lifestyle-related diseases such as including cardiovascular, diabetes, and immunological disorders.
Branded Generic Drugs are dominating, as they provide a balance between affordability and quality. They are widely famous in Romania for treating chronic conditions while keeping prices less, driving strong use in hospitals and retail pharmacies.
Small Molecules dominate, due to their wide usage in chronic and acute conditions, ease of manufacturing, and price range compared to biologics. Biologics and biosimilars demand are increasing particularly in immunology.
Cardiovascular Diseases dominate this segment due to high numbers in aging population and rising lifestyle diseases. Other indications such as immunology and respiratory diseases are also growing with increased awareness and treatment options.
Oral drugs dominate the Romania Pharmaceutical Market Share, due to their ease of use, patient compliance, and cost efficiency. Injectable and topical formulations are used in therapies, while intra-nasal and other methods remain limited but innovative.
Retail Pharmacies dominate as the main source for medicines due to their easy accessibility, convenience, and strong demand in urban and semi-urban areas. Hospital pharmacies are also important for prescription drugs.
The report offers a comprehensive study of the following Romania Pharmaceutical Market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 Romania Pharmaceutical Market Overview |
| 3.1 Romania Country Macro Economic Indicators |
| 3.2 Romania Pharmaceutical Market Revenues & Volume, 2022 & 2032F |
| 3.3 Romania Pharmaceutical Market - Industry Life Cycle |
| 3.4 Romania Pharmaceutical Market - Porter's Five Forces |
| 3.5 Romania Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2022 & 2032F |
| 3.6 Romania Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
| 3.7 Romania Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
| 3.8 Romania Pharmaceutical Market Revenues & Volume Share, By Indication, 2022 & 2032F |
| 3.9 Romania Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2022 & 2032F |
| 3.10 Romania Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
| 4 Romania Pharmaceutical Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing healthcare expenditure in Romania |
| 4.2.2 Aging population leading to higher demand for pharmaceuticals |
| 4.2.3 Growing prevalence of chronic diseases in the country |
| 4.3 Market Restraints |
| 4.3.1 Stringent regulations and pricing policies in the pharmaceutical sector |
| 4.3.2 Lack of proper healthcare infrastructure in certain regions of Romania |
| 5 Romania Pharmaceutical Market Trends |
| 6 Romania Pharmaceutical Market, By Types |
| 6.1 Romania Pharmaceutical Market, By Prescription Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 Romania Pharmaceutical Market Revenues & Volume, By Prescription Type, 2022- 2032F |
| 6.1.3 Romania Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2022- 2032F |
| 6.1.4 Romania Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2022- 2032F |
| 6.2 Romania Pharmaceutical Market, By Drug Type |
| 6.2.1 Overview and Analysis |
| 6.2.2 Romania Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2022- 2032F |
| 6.2.3 Romania Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2022- 2032F |
| 6.2.4 Romania Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2022- 2032F |
| 6.3 Romania Pharmaceutical Market, By Drug Class |
| 6.3.1 Overview and Analysis |
| 6.3.2 Romania Pharmaceutical Market Revenues & Volume, By Small Molecules, 2022- 2032F |
| 6.3.3 Romania Pharmaceutical Market Revenues & Volume, By Biologics, 2022- 2032F |
| 6.3.4 Romania Pharmaceutical Market Revenues & Volume, By Biosimilars, 2022- 2032F |
| 6.4 Romania Pharmaceutical Market, By Indication |
| 6.4.1 Overview and Analysis |
| 6.4.2 Romania Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2022- 2032F |
| 6.4.3 Romania Pharmaceutical Market Revenues & Volume, By Immunology, 2022- 2032F |
| 6.4.4 Romania Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2022- 2032F |
| 6.4.5 Romania Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2022- 2032F |
| 6.4.6 Romania Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2022- 2032F |
| 6.4.7 Romania Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2022- 2032F |
| 6.5 Romania Pharmaceutical Market, By Mode of Administration |
| 6.5.1 Overview and Analysis |
| 6.5.2 Romania Pharmaceutical Market Revenues & Volume, By Topical, 2022- 2032F |
| 6.5.3 Romania Pharmaceutical Market Revenues & Volume, By Oral, 2022- 2032F |
| 6.5.4 Romania Pharmaceutical Market Revenues & Volume, By Injectable, 2022- 2032F |
| 6.5.5 Romania Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2022- 2032F |
| 6.5.6 Romania Pharmaceutical Market Revenues & Volume, By Others, 2022- 2032F |
| 6.6 Romania Pharmaceutical Market, By Distribution Channel |
| 6.6.1 Overview and Analysis |
| 6.6.2 Romania Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2022- 2032F |
| 6.6.3 Romania Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2022- 2032F |
| 6.6.4 Romania Pharmaceutical Market Revenues & Volume, By Drug Stores, 2022- 2032F |
| 6.6.5 Romania Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2022- 2032F |
| 7 Romania Pharmaceutical Market Import-Export Trade Statistics |
| 7.1 Romania Pharmaceutical Market Export to Major Countries |
| 7.2 Romania Pharmaceutical Market Imports from Major Countries |
| 8 Romania Pharmaceutical Market Key Performance Indicators |
| 8.1 Percentage of the population covered by health insurance |
| 8.2 Number of new drug approvals by regulatory authorities in Romania |
| 8.3 Investment in research and development of pharmaceuticals in the country |
| 8.4 Rate of adoption of innovative healthcare technologies in Romania |
| 8.5 Number of partnerships and collaborations between local and international pharmaceutical companies |
| 9 Romania Pharmaceutical Market - Opportunity Assessment |
| 9.1 Romania Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2022 & 2032F |
| 9.2 Romania Pharmaceutical Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
| 9.3 Romania Pharmaceutical Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
| 9.4 Romania Pharmaceutical Market Opportunity Assessment, By Indication, 2022 & 2032F |
| 9.5 Romania Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2022 & 2032F |
| 9.6 Romania Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
| 10 Romania Pharmaceutical Market - Competitive Landscape |
| 10.1 Romania Pharmaceutical Market Revenue Share, By Companies, 2022 & 2032F |
| 10.2 Romania Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |